Financial statements Efferta Pharma
Cash flow statement of Efferta Pharma
Company age:
Age:
5 y. 8 d.
Share capital:
Share capital:
500 000 PLN
Cash inflows of EFFERTA PHARMA
|
Year
|
2024
|
|---|---|
| Net cash from operating expenses | 9 370 372,29 |
| Net cash flow from investing activities | -7 462 303,13 |
| Net cash flow from financial activities | -3 783 933,85 |
| Total net cash flow | -1 875 864,69 |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.